The relationship between exacerbated diabetic peripheral neuropathy and metformin treatment in type 2 diabetes mellitus
Abstract Metformin-treated diabetics (MTD) showed a decrease in cobalamin, a rise in homocysteine, and methylmalonic acid, leading to accentuated diabetic peripheral neuropathy (DPN). This study aimed to determine whether or not metformin is a risk factor for DPN. We compared MTD to non-metformin-tr...
Main Authors: | Manal Mohammed Hashem, Ahmed Esmael, Abdelfattah Kasem Nassar, Mohammed El-Sherif |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-81631-8 |
Similar Items
-
Metformin treatment and risk of diabetic peripheral neuropathy in patients with type 2 diabetes mellitus in Beijing, China
by: Ruotong Yang, et al.
Published: (2023-02-01) -
5 Neuroprotective effects of metformin in diabetic peripheral neuropathy
by: Roshan Dhanapalaratnam, et al.
Published: (2024-08-01) -
The association of metformin use with vitamin B12 deficiency and peripheral neuropathy in Saudi individuals with type 2 diabetes mellitus.
by: Turki J Alharbi, et al.
Published: (2018-01-01) -
The prevalence of diabetic peripheral neuropathy in youth with diabetes mellitus
by: Piengjai Sophausvaporn, et al.
Published: (2023-02-01) -
Study of Vitamin B 12 deficiency and peripheral neuropathy in metformin-treated early Type 2 diabetes mellitus
by: Rudra Prasad Roy, et al.
Published: (2016-01-01)